Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6

NCT: NCT06241547 · ACTIVE_NOT_RECRUITING

NCT IDNCT06241547
StatusACTIVE_NOT_RECRUITING
Start Date2024-01-12
Completion2026-03-30

Brief Summary

This study aims to certify the effectiveness of percutaneous electrical nerve stimulation at Pericardium 6 (PC6) via a wearable equipment during perioperative period on preventing postoperative nausea and vomiting.

Frequently Asked Questions

What is PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6?

PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6 is a clinical trial registered under NCT06241547. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06241547?

The current status of NCT06241547 (PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6) is: ACTIVE_NOT_RECRUITING.

When did PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6 start?

PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6 started on 2024-01-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑